跳到正文

INM — Inmed Pharmaceuticals Inc 机构持仓 · 2026年Q2

谁持有 Inmed Pharmaceuticals Inc(INM)?2026年Q2(报告期截至 2026-06-30)共有 22 家机构在 SEC 13F 申报中报告持有,合计 418.23 万美元。前几大持有机构:ADAR1 Capital Management, LLC(120.00 万美元)、Vivo Capital, LLC(120.00 万美元)、Squadron Capital Management LLC(50.38 万美元)。

排名机构市值股数变动
1ADAR1 Capital Management, LLC$1.2M800,000新建仓
2Vivo Capital, LLC$1.2M798,377新建仓
3Squadron Capital Management LLC$503,750325,000新建仓
4Ikarian Capital, LLC$379,788245,025新建仓
5Ursa Fund Management, LLC$194,990125,800新建仓
6SUVRETTA CAPITAL MANAGEMENT, LLC$155,000100,000新建仓
7BOOTHBAY FUND MANAGEMENT, LLC$115,07874,244新建仓
8SABBY MANAGEMENT, LLC$69,70444,970减持
9JANE STREET GROUP, LLC$66,77143,078新建仓
10VR ADVISER, LLC$50,66232,685新建仓
11CITADEL ADVISORS LLC$40,43026,084减持
12SEVEN GRAND MANAGERS, LLC$38,75025,000新建仓
13Scientech Research LLC$23,96515,461新建仓
14Crestwood Advisors Group, LLC$23,09514,900新建仓
15TWO SIGMA SECURITIES, LLC$16,96510,945减持
16Stratos Wealth Partners, LTD.$16,67810,760新建仓
17Private Wealth Management Group, LLC$7,7505,000持平
18Banque Cantonale Vaudoise$1,0006持平
19SBI Securities Co., Ltd.$465300持平
20Federation des caisses Desjardins du Quebec$42持平
21Virtu Financial LLC$00清仓
22UBS Group AG$00清仓

来源:SEC 13F 申报文件 · 截至 2026-06-30